Management of a Patient with HbA1c of 6.6% Without Anti-Diabetic Medications

Understanding the HbA1c Value

An HbA1c of 6.6% corresponds to an estimated average glucose of approximately 143 mg/dL, which is within an acceptable range for most patients 2
The American Diabetes Association recommends an HbA1c target of <7% for most nonpregnant adults, and an HbA1c of 6.6% is already below this standard target 1

The American Diabetes Association suggests maintaining current lifestyle modifications that have successfully achieved this level of glycemic control, as the current HbA1c is already at target 1
Regular monitoring of HbA1c every 3-6 months is recommended to ensure continued glycemic stability 2
Consider individualized assessment based on patient-specific factors, such as disease duration, life expectancy, presence of comorbidities, and risk of hypoglycemia, to determine if the current HbA1c level is appropriate 1

Maintaining an HbA1c of 6.6% can reduce the risk of microvascular complications, such as retinopathy, nephropathy, and neuropathy 1
Implementing this level of glycemic control early after diagnosis may also reduce the risk of macrovascular disease in the long term 1
The "metabolic memory" effect may contribute to improved long-term outcomes with good glycemic control 4

Starting anti-diabetic medications at an HbA1c level of 6.6% could lead to unnecessary treatment burden, potential side effects, and risk of hypoglycemia, as the absolute risk reduction of further lowering A1C from 6.6% to lower levels becomes much smaller compared to the potential risks 1
If using continuous glucose monitoring, target time in range >70% (70-180 mg/dL) to better assess glycemic patterns 4
Certain conditions, such as hemolysis, blood loss, or hemoglobin variants, can affect HbA1c reliability, so it is essential to verify that the A1c correlates with the patient's clinical situation 2